126 related articles for article (PubMed ID: 26236924)
1. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
Li W; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):407-11. PubMed ID: 26236924
[TBL] [Abstract][Full Text] [Related]
2. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
3. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
[TBL] [Abstract][Full Text] [Related]
4. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, "real-life" trial.
Luo XD; Chen XF; Zhou Y; Chen XP
J Viral Hepat; 2017 Nov; 24 Suppl 1():36-42. PubMed ID: 29082651
[TBL] [Abstract][Full Text] [Related]
6. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
[TBL] [Abstract][Full Text] [Related]
7. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
Lin YS; Shih SC; Wang HY; Lin CC; Chang CW; Chen MJ
BMC Gastroenterol; 2017 Jan; 17(1):22. PubMed ID: 28137301
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of 104-week sequential therapy with telbivudine or entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24-week therapy with pegylated interferon-α-2a].
Luo XD; Chen XP; Chen R; Chen XF; Huang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):241-5. PubMed ID: 27470620
[TBL] [Abstract][Full Text] [Related]
9. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.
Tsai MC; Lee CM; Chiu KW; Hung CH; Tung WC; Chen CH; Tseng PL; Chang KC; Wang JH; Lu SN; Yen YH; Hu TH
J Antimicrob Chemother; 2012 Mar; 67(3):696-9. PubMed ID: 22174039
[TBL] [Abstract][Full Text] [Related]
10. Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B.
Qi X; Wang J; Chen L; Huang Y; Qin Y; Mao R; Zhang J
Medicine (Baltimore); 2015 Apr; 94(15):e646. PubMed ID: 25881837
[TBL] [Abstract][Full Text] [Related]
11. [Short-term results of telbivudine versus entecavir treatments in HBeAg-positive chronic hepatitis B patients in China].
Shi KQ; Zhang DZ; Guo SH; He H; Wang ZY; Shi XF; Zeng WQ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):641-5. PubMed ID: 18822200
[TBL] [Abstract][Full Text] [Related]
12. [A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis].
Lian J; Han T; Xiang H; Liu F; Lyu H; Gao Y; Wang F
Zhonghua Gan Zang Bing Za Zhi; 2015 Oct; 23(10):733-7. PubMed ID: 26573188
[TBL] [Abstract][Full Text] [Related]
13. Telbivudine versus entecavir for nucleos(t)ide-naive HBeAg-positive chronic hepatitis B: a meta-analysis.
Liu H; Wang X; Wan G; Yang Z; Zeng H
Am J Med Sci; 2014 Feb; 347(2):131-8. PubMed ID: 23563307
[TBL] [Abstract][Full Text] [Related]
14. [Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients].
Huang J; Chen XP; Chen XF; Chen WL; Chen R; Ma XJ; Luo XD
Zhonghua Gan Zang Bing Za Zhi; 2011 Mar; 19(3):178-81. PubMed ID: 21586234
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
Law ST; Lee MK; Lee AS; Tung Y; Li KK
J Dig Dis; 2016 May; 17(5):325-33. PubMed ID: 27085094
[TBL] [Abstract][Full Text] [Related]
16. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
He J; Ning HB; Zeng YL; Li W; Li K; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
[No Abstract] [Full Text] [Related]
17. Renal Function in Nucleos(t)ide Analog-Treated Patients With Chronic Hepatitis B: A Systematic Literature Review and Network Meta-Analysis.
Chan HL; Shaikh J; Gupta S; Hamed K
Adv Ther; 2016 May; 33(5):862-75. PubMed ID: 27146675
[TBL] [Abstract][Full Text] [Related]
18. The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.
Sun J; Xie Q; Tan D; Ning Q; Niu J; Bai X; Fan R; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Jia J; Hou J
Hepatology; 2014 Apr; 59(4):1283-92. PubMed ID: 24382690
[TBL] [Abstract][Full Text] [Related]
19. A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.
Zhang Y; Hu P; Qi X; Ren H; Mao RC; Zhang JM
Clin Microbiol Infect; 2016 Mar; 22(3):287.e1-9. PubMed ID: 26548508
[TBL] [Abstract][Full Text] [Related]
20. Telbivudine improves renal function in patients with chronic hepatitis B.
Gane EJ; Deray G; Liaw YF; Lim SG; Lai CL; Rasenack J; Wang Y; Papatheodoridis G; Di Bisceglie A; Buti M; Samuel D; Uddin A; Bosset S; Trylesinski A
Gastroenterology; 2014 Jan; 146(1):138-146.e5. PubMed ID: 24067879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
